Vetiqure AB, the Animal care division of Scandinavian ChemoTech and Royal Veterinary College, to establish a Centre of Excellence for TSE
Following a six-month evaluation, the Royal Veterinary College (RVC) will now aquire the vetIQure™ system and make Tumour Specific Electroporation (TSE) one of the standard therapies offered by RVC Equine. This equipment will be funded by the RVC Animal Care Trust. Vetiqure and the RVC are planning to establish a Centre of Excellence for the TSE technology.During the trials, the equine team, led by Drs. Michael Hewetson and Andy Fiske-Jackson, has evaluated the TSE on patients suffering from both melanocytic tumours and sarcoids. Although the follow-up period is not yet complete, the